Image-guided radiotherapy for localized prostate cancer: treating a moving target.
about
A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer.Detecting prostate cancer and prostatic calcifications using advanced magnetic resonance imagingComparison of measurement methods with a mixed effects procedure accounting for replicated evaluations (COM3PARE): method comparison algorithm implementation for head and neck IGRT positional verificationThree-dimensional surface and ultrasound imaging for daily IGRT of prostate cancerPreliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer.Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT.Determining intrafractional prostate motion using four dimensional ultrasound system.Initial results for patient setup verification using transperineal ultrasound and cone beam CT in external beam radiation therapy of prostate cancer.Novel treatment methods for localized prostate cancer: hypofractionated robotic radiation therapy and adjuvant chemotherapy.Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naïve prostate cancer.Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT).Integral Dose-Based Inverse Optimization May Reduce Side Effects in Radiotherapy of Prostate Carcinoma.Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO).Beam distortion due to gold fiducial markers during salvage high-intensity focused ultrasound in the prostate.Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.Image guided dose escalated prostate radiotherapy: still room to improve.Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy.Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity.Deformable image registration for adaptive radiotherapy with guaranteed local rigidity constraints.Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients.Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer.Utilization of cone-beam CT for offline evaluation of target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignment.Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapyElectronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties.Six-Dimensional Correction of Intra-Fractional Prostate Motion with CyberKnife Stereotactic Body Radiation Therapy.Optimized hybrid megavoltage-kilovoltage imaging protocol for volumetric prostate arc therapycExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancer.ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.Utilization of cone beam CT for reconstruction of dose distribution delivered in image-guided radiotherapy of prostate carcinoma - bony landmark setup compared to fiducial markers setup.Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer.National survey on image-guided radiotherapy practice in New Zealand.Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy : Comparison of gold marker-based registrations with native MVCT.Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy.Volumetric-modulated arc therapy and intensity-modulated radiation therapy treatment planning for prostate cancer with flattened beam and flattening filter free linear accelerators.Hierarchical enhanced non-rigid registration for target volume correction and propagation for adaptive external beam radiotherapy of carcinoma of the prostate.Experimental study of beam distortion due to fiducial markers during salvage HIFU in the prostate.Using daily diagnostic quality images to validate planning margins for prostate interfractional variationsQuantification of the margin required for treating intraprostatic lesions.A simple algorithm to assess patient suitability for Calypso‐seed implantation for four‐dimensional prostate localization.
P2860
Q33514222-1588B398-49AD-482D-8343-67352D806BA0Q33897274-585AF938-D931-45DB-9D92-596471325543Q35756671-9EF30C4C-5CAA-4B86-8942-B93A31F721A9Q36220920-E8DA40CF-2E2B-49A7-B338-96FDB9062871Q36325030-4BF58D9B-F731-4704-A55F-D62D288CBA9DQ36987015-D2CB5461-725B-43BD-9A35-1EAB3998FFDEQ37099720-9A02FEC8-81B4-4AE7-AA7C-25A8C0A4D485Q37403021-183DEB47-E095-4553-82A0-D120588AB601Q37546045-8F41AC06-01BD-4B2B-945A-481D800D2803Q38172209-F70AD5B7-90BA-4BEA-A0FC-0E0D4AFC9429Q38556103-1702D0B6-7A73-410A-B349-52069F7D1480Q38904590-CF2EA395-2387-40F7-95B9-C442E9595F3FQ38947922-D07900E7-562F-476C-9E62-91DED12292DAQ39061948-EA5BC0E1-5533-4B8E-A474-7FBBA0EF2A1BQ39135519-8B4C108C-D115-4CEE-8472-C2537E2F0DCCQ39932645-2A3230CE-E288-447F-A873-0AF8D90CBCFEQ40298928-55F66EAA-9686-44B2-8983-5D97D7267BABQ40387434-49DCA9E7-E7E3-446F-808A-80384B8BFCACQ41129749-D1B0AAB8-450E-4891-922F-ECD11DDF2212Q41378041-F619E1CA-26D6-4794-B2A5-008CBEEE735BQ41531397-70BDD8B8-C298-4C7E-A783-4435AF214615Q41823901-71597256-882F-42B1-B7DB-E6F6A14772E2Q42045474-BE054FB9-1F98-4376-8CFA-CCFFD20D41D3Q42046524-FCA88D88-7A47-4C19-AB9E-919190BE679CQ42175056-C4DA161C-0A13-452F-A2AB-D54A8DFA5000Q42789082-97D13014-2317-4FBD-9DEE-73A08A103AA9Q43076481-8ADA446E-7745-4E2C-85AF-18B2F213F47DQ43379694-89F4E46C-7596-4295-AC92-7CA880222646Q43630974-63718AD8-7894-4D65-AD54-955E023493B0Q46838608-17FEC9E1-4892-435C-8ED3-2F3E8241644AQ48125754-0F448F47-B7F9-43BC-9FDC-BC31E49D0FE6Q48202274-6645802B-39CA-47A5-90DD-ED2CC237616FQ48802477-D063F5CD-D43C-4635-9810-C884EA00B2DBQ50249659-55DD7A5A-2C0D-4D19-B99D-8A860CD497FEQ51164161-EE49260F-A90A-4977-9A87-6775DADCC2E3Q52626554-09B5AF70-4566-416C-A007-8D12DFA1A477Q52983030-3F4B22FD-4D9B-490B-B741-03637C1BBEB7Q53103459-DC2CBEF1-241E-4026-884E-E793F3360B15Q55002790-05D2090B-24B8-44B3-A6D0-104267999CCC
P2860
Image-guided radiotherapy for localized prostate cancer: treating a moving target.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Image-guided radiotherapy for localized prostate cancer: treating a moving target.
@en
Image-guided radiotherapy for localized prostate cancer: treating a moving target.
@nl
type
label
Image-guided radiotherapy for localized prostate cancer: treating a moving target.
@en
Image-guided radiotherapy for localized prostate cancer: treating a moving target.
@nl
prefLabel
Image-guided radiotherapy for localized prostate cancer: treating a moving target.
@en
Image-guided radiotherapy for localized prostate cancer: treating a moving target.
@nl
P2093
P1476
Image-guided radiotherapy for localized prostate cancer: treating a moving target.
@en
P2093
Katja M Langen
Omar A Zeidan
Patrick A Kupelian
Sanford L Meeks
Twyla R Willoughby
P356
10.1016/J.SEMRADONC.2007.09.008
P577
2008-01-01T00:00:00Z